JP2022525202A5 - - Google Patents
Info
- Publication number
- JP2022525202A5 JP2022525202A5 JP2021555469A JP2021555469A JP2022525202A5 JP 2022525202 A5 JP2022525202 A5 JP 2022525202A5 JP 2021555469 A JP2021555469 A JP 2021555469A JP 2021555469 A JP2021555469 A JP 2021555469A JP 2022525202 A5 JP2022525202 A5 JP 2022525202A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- pharmaceutical product
- pharmaceutically acceptable
- product according
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962819162P | 2019-03-15 | 2019-03-15 | |
| US62/819,162 | 2019-03-15 | ||
| PCT/IB2020/000177 WO2020188352A1 (en) | 2019-03-15 | 2020-03-13 | A method for treating pulmonary arterial hypertension and associated pulmonary arterial hypertension and daily dosing |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022525202A JP2022525202A (ja) | 2022-05-11 |
| JP2022525202A5 true JP2022525202A5 (cg-RX-API-DMAC7.html) | 2023-02-13 |
Family
ID=71092560
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021555469A Pending JP2022525202A (ja) | 2019-03-15 | 2020-03-13 | 肺動脈性肺高血圧症および各種疾患に伴う肺動脈性肺高血圧症の治療法と1日あたりの投薬量 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US11576915B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3938043A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2022525202A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20210139293A (cg-RX-API-DMAC7.html) |
| CN (1) | CN113784717A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020244278A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3133589A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2021011224A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020188352A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2019382168A1 (en) * | 2018-11-16 | 2021-06-03 | Altavant Sciences Gmbh | A method for treating pulmonary arterial hypertension and associated pulmonary arterial hypertension |
| CN113557022A (zh) * | 2019-01-30 | 2021-10-26 | 阿尔塔万特科学公司 | 用罗达司他乙酯治疗肺动脉高压的给药方案和方法 |
| CN113784717A (zh) | 2019-03-15 | 2021-12-10 | 阿尔塔万特科学公司 | 一种治疗肺动脉高压和相关性肺动脉高压的方法以及每日给药 |
| WO2023062595A1 (en) * | 2021-10-14 | 2023-04-20 | Altavant Sciences Gmbh | Treatment of subjects having pulmonary arterial hypertension with rodatristat ethyl |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101815534A (zh) * | 2007-07-11 | 2010-08-25 | 莱西肯医药有限公司 | 用于治疗肺动脉高压以及相关疾病和病症的方法和组合物 |
| UA119247C2 (uk) | 2013-09-06 | 2019-05-27 | РОЙВЕНТ САЙЕНСИЗ ҐмбГ | Спіроциклічні сполуки як інгібітори триптофангідроксилази |
| US9399741B2 (en) | 2013-10-09 | 2016-07-26 | Uop Llc | Methods and apparatuses for desulfurizing hydrocarbon streams |
| KR20210102887A (ko) * | 2018-11-14 | 2021-08-20 | 알타반트 사이언시스 게엠베하 | 말초 세로토닌과 관련된 질병 또는 장애를 치료하기 위한 트립토판 하이드록실라제 1 (tph1)의 결정질 스피로사이클릭 화합물 억제제 |
| AU2019382168A1 (en) * | 2018-11-16 | 2021-06-03 | Altavant Sciences Gmbh | A method for treating pulmonary arterial hypertension and associated pulmonary arterial hypertension |
| US20200188398A1 (en) | 2018-12-17 | 2020-06-18 | Altavant Sciences Gmbh | Method for treating sarcoidosis-associated pulmonary hypertension |
| WO2020128614A1 (en) | 2018-12-17 | 2020-06-25 | Altavant Sciences Gmbh | Method for treating interstital lung disease |
| CN113557022A (zh) | 2019-01-30 | 2021-10-26 | 阿尔塔万特科学公司 | 用罗达司他乙酯治疗肺动脉高压的给药方案和方法 |
| CN113784717A (zh) | 2019-03-15 | 2021-12-10 | 阿尔塔万特科学公司 | 一种治疗肺动脉高压和相关性肺动脉高压的方法以及每日给药 |
-
2020
- 2020-03-13 CN CN202080033296.0A patent/CN113784717A/zh active Pending
- 2020-03-13 AU AU2020244278A patent/AU2020244278A1/en not_active Abandoned
- 2020-03-13 EP EP20732658.8A patent/EP3938043A1/en not_active Withdrawn
- 2020-03-13 CA CA3133589A patent/CA3133589A1/en active Pending
- 2020-03-13 WO PCT/IB2020/000177 patent/WO2020188352A1/en not_active Ceased
- 2020-03-13 US US16/818,236 patent/US11576915B2/en active Active
- 2020-03-13 MX MX2021011224A patent/MX2021011224A/es unknown
- 2020-03-13 JP JP2021555469A patent/JP2022525202A/ja active Pending
- 2020-03-13 KR KR1020217031156A patent/KR20210139293A/ko not_active Abandoned
-
2023
- 2023-01-04 US US18/149,992 patent/US20240024316A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022507533A5 (cg-RX-API-DMAC7.html) | ||
| US9771361B2 (en) | Inhibitors of influenza viruses replication | |
| JP7697885B2 (ja) | 化合物の製剤およびそれらの使用 | |
| CN100448439C (zh) | 用于头痛、偏头痛、恶心和呕吐的药物组合物 | |
| WO2015130966A1 (en) | Antiviral agents | |
| CN102389423A (zh) | 一种含有布洛芬钠盐的药用组合物 | |
| US20190233470A1 (en) | Chiral specific boron-containing compounds and their use in treating cancer or amyloidosis | |
| JP2024019691A (ja) | 肺動脈性高血圧症および他疾患に関連する肺動脈性肺高血圧症の治療法 | |
| CA2446748A1 (en) | Anxiolytic marcgraviaceae compositions containing betulinic acid, betulinic acid derivatives, and methods | |
| CN113784717A (zh) | 一种治疗肺动脉高压和相关性肺动脉高压的方法以及每日给药 | |
| EP4045058A1 (fr) | Utilisation de nictotinamide mononucléotide (nmn) pour la prevention et/ou le traitement de la polyarthrite rhumatoïde et compositions correspondantes | |
| TW200306185A (en) | Combinations comprising EPOTHILONES and anti-metabolites | |
| JP2007530688A (ja) | 肝毒性が減少した組成物 | |
| CN100372533C (zh) | 腹泻为主大肠激惹综合征的治疗制剂 | |
| JP2018035165A (ja) | S−(+)−フルルビプロフェンを含む原薬の調製物、医薬組成物、そして剤形 | |
| RU2358723C1 (ru) | Средство, обладающее антипохмельным действием, биологически активная добавка, фармацевтическая композиция, лекарственное средство и способ получения | |
| AU2013368298B2 (en) | Methods and compositions for administration of oxybutynin | |
| JP5376785B2 (ja) | 医薬組成物 | |
| JP2010536827A (ja) | ある種の炎症性障害の治療に有用なカルボニルアミノ誘導体 | |
| KR100379155B1 (ko) | 새로운 진통제 조성물 | |
| JP6421873B2 (ja) | テノホビルジソプロキシルの新規塩 | |
| TW536400B (en) | Pharmaceutical composition for the treatment of immunodeficiency disease which cause by HIV infection | |
| TW200826923A (en) | A composition for the treatment and prevention of peptic ulcer | |
| JP2026516115A (ja) | 胃食道逆流症(GERD)を治療するためのリナプラザングルレート(linaprazan glurate) | |
| KR20220014025A (ko) | 나파모스타트 메실레이트와 덱사메타손 또는 그 염을 유효성분으로 포함하는 약학적 조성물 |